Literature DB >> 7249417

Dialyzable leukocyte extract therapy in immunodepressed patients with cutaneous leishmaniasis.

O Delgado, E L Romano, E Belfort, F Pifano, J V Scorza, Z Rojas.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7249417     DOI: 10.1016/0090-1229(81)90078-7

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


× No keyword cloud information.
  5 in total

1.  Serum Derived Transfer Factor Stimulates the Innate Immune System to Improve Survival Traits in High Risk Pathogen Scenarios.

Authors:  Bridget V Willeford; Trudy Shapiro-Dunlap; Kenneth O Willeford
Journal:  Drug Dev Res       Date:  2017-06-22       Impact factor: 4.360

2.  Transfer factors as immunotherapy and supplement of chemotherapy in experimental pulmonary tuberculosis.

Authors:  R A Fabre; T M Pérez; L D Aguilar; M J Rangel; I Estrada-Garcìa; R Hernández-Pando; S Estrada Parra
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

3.  Antiviral mode of action of bovine dialyzable leukocyte extract against human immunodeficiency virus type 1 infection.

Authors:  Humberto H Lara; Liliana Ixtepan-Turrent; Elsa N Garza-Treviño; Jose I Badillo-Almaraz; Cristina Rodriguez-Padilla
Journal:  BMC Res Notes       Date:  2011-11-01

4.  Herpes murine model as a biological assay to test dialyzable leukocyte extracts activity.

Authors:  Nohemí Salinas-Jazmín; Sergio Estrada-Parra; Miguel Angel Becerril-García; Alberto Yairh Limón-Flores; Said Vázquez-Leyva; Emilio Medina-Rivero; Lenin Pavón; Marco Antonio Velasco-Velázquez; Sonia Mayra Pérez-Tapia
Journal:  J Immunol Res       Date:  2015-04-23       Impact factor: 4.818

5.  Histopathology of murine toxoplasmosis under treatment with dialyzable leukocyte extract.

Authors:  Beatriz Eugenia Fuentes-Castro; Juan Gerardo Reyes-García; María Teresa Valenzuela-Vargas; Federico Martínez-Gómez
Journal:  Mem Inst Oswaldo Cruz       Date:  2017-11       Impact factor: 2.743

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.